Efficacy evaluation of the combination therapy of sorafenib and transarterial chemoembolization for unresectable HCC: a systematic review and meta-analysis of comparative studies

BACKGROUND: Sorafenib and transarterial chemoembolization (TACE) are the standard treatments recommended by guidelines for unresectable hepatocellular carcinoma (HCC). Although previous studies have shown the combination therapy of sorafenib and TACE to be safe, there is no consensus regarding its e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Autores principales: Li, Huichen, Li, Songlun, Geng, Jie, Zhao, Shoujie, Tan, Kai, Yang, Zhenyu, Feng, Dayun, Liu, Lei
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7214895/
https://ncbi.nlm.nih.gov/pubmed/32411763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.115
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares